Issues
Neutrons in cancer treatment. Past, present and future. Review
«Radiation and Risk», 2024, vol. 33, No. 1, pp.40-54
DOI: 10.21870/0131-3878-2024-33-1-40-54
Authors
Mardynsky Yu.S. – Chief Researcher, Corr. Member of RAS, MD, Prof.Gulidov I.A. – Head of Dep., MD, Prof.
Ivanov S.A. – Director, Corr. Member of RAS, MD, Prof. of RUDN University Dep.
Gordon K.B. – Sen. Researcher, C. Sc., Med., Assoc. Prof. of RUDN University. A. Tsyb MRRC. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: +7 (484) 399-33-91; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Kaprin A.D. – General Director, Director of P. Hertsen MORI, Head of RUDN University Dep., Academician of RAS, MD, Prof. NMRRC.
1 A. Tsyb MRRC, Obninsk
2 NMRRC, Obninsk
3 Peoples' Friendship University of Russia named after Patrice Lumumba, Moscow
4 P. Hertsen MORI, Moscow
Abstract
For many decades, neutrons have been actively used in the treatment of various cancer diseases. In the light of recent advances in conventional photon therapy, interest in neutrons has almost faded, despite their unique biological features. At the same time, neutron-capture therapy is actively developing, the concept of which is based on the high precision of the treatment method, allowing to minimize the toxicity of the treatment. Another way of using neutrons deserves attention – as sources for contact brachytherapy. In Russia, various neutron therapy methods have been studied in depth, ranging from fundamental aspects to direct wide use in various clinical situations. Such capabilities were provided by the extensive research infrastructure of particle physics, and its accessibility to researchers and clinicians. In the modern clinical perspective, neutron therapy can be an effective treatment option for certain clinical indications. Such cases are traditionally referred to as radioresistant tumors, which are considered to be low sensitive to irradiation. This mini-review recall the history of the use of neutrons since their discovery and to the present days, as well it discusses their role in the further development of radiotherapy.
Key words
oncology, radiation therapy, neutrons, neutron-capture, brachytherapy, radiotherapy, radioresistance, photon-neutron therapy, external-beam neutron therapy, hadron therapy, particle therapy, radiology, nuclear medicine and imaging.
References
1. Chadwick J. Possible existence of a neutron. Nature, 1932, vol. 129, pp. 312.
2. Stone R. Neutron therapy and specific ionization. Am. J. Roentgenol. Radium. Ther., 1948, vol. 59, no. 6, pp. 771-785.
3. Silini G., Miller R.G. A model for the study of X-ray and neutron effects on tumor cell populations. Tumori J., 1964, vol. 50, no. 1, pp. 13-24.
4. Hornsey S., Field S. The RBE of cyclotron neutrons for effects on normal tissues. Eur. J. Cancer, 1974, vol. 10, no. 4, pp. 231-234.
5. Jones B. Clinical radiobiology of fast neutron therapy: what was learnt? Front. Oncol., 2020, vol. 10, pp. 1537.
6. Catterall M., Bewley D. Fast neutrons in the treatment of cancer. London: Academic, 1979. 394 p.
7. Catterall M. First randomized clinical trial of fast neutrons compared with photons in advanced carcinoma of the head and neck. Clin. Otolaryngol. Allied Sci., 1977, vol. 2, no. 4, pp. 359-372.
8. Lindsley K.L., Cho P., Stelzer K.J., Koh W.J., Austin-Seymour M., Russell K.J., Laramore G.E., Griffin T.W. Clinical trials of neutron radiotherapy in the United States. Bull. Cancer Radiother., 1996, vol. 83 (Suppl.), pp. 78s-86s.
9. Tsunemoto H. Fast neutron therapy in the National Institute of Radiological Sciences; 10 years’ experience and future study. Gan No Rinsho, 1988, vol. 34, no. 13, pp. 1833-1838.
10. Gulidov I.A., Aslanidi I.P. On the state and prospects of development of remote neutron therapy. Voprosy Onkologii – Problems in Oncology, 2014, vol. 60, no. 4, pp. 408-412. (In Russian).
11. Goodhead D.T. Neutrons are forever! Historical perspectives. Int. J. Radiat. Biol., 2019, vol. 95, no. 7, pp. 957-984.
12. Douglas J.G., Koh W.J., Austin-Seymour M., Laramore G.E. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch. Otolaryngol. Head Neck Surg., 2003, vol. 129, no. 9, pp. 944-948.
13. Timoshchuk M.A., Dekker P., Hippe D.S., Parvathaneni U., Liao J.J., Laramore G.E., Dillon J.K. The efficacy of neutron radiation therapy in treating salivary gland malignancies. Oral Oncol., 2019, vol. 88, pp. 51-57.
14. Liao J.J., Parvathaneni U., Laramore G.E., Thompson J.A.., Bhatia S, Futran N.D., Bhrany A.D., Hawes S.E., Ladra M. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck, 2014, vol. 36, no. 8, pp. 1162-1167.
15. Mardynsky Y.S., Sysoyev A.S., Andreyev V.G., Gulidov I.A. Preliminary results of clinical application of reactor fast neutrons in radiation and combined therapy of patients with laryngeal carcinoma. Strahlenther Onkol., 1991, vol. 167, no. 3, pp. 169-171.
16. Steingraber M., Lessel A., Jahn U. Fast neutron therapy in treatment of soft tissue sarcoma – the Berlin-Buch study. Bull. Cancer Radiother., 1996, vol. 83 (Suppl.), pp. 122s-124s.
17. Breteau N., Destembert B., Favre A., Sabattier R., Schlienger M. An interim assessment of the experience of fast neutron boost in inoperable rectal carcinomas in Orléans. Bull. Cancer., 1986, vol. 73, no. 5, pp. 591-595.
18. Catterall M., Errington R.D., Bewley D.K. Fast neutrons in the treatment of locally advanced breast cancer. Eur. J. Surg. Oncol., 1987, vol. 13, no. 4, pp. 315-319.
19. Koh W.J., Griffin T.W., Laramore G.E., Stelzer K.J., Russell K.J. Fast neutron radiation therapy. Results of phase III randomized trials in head and neck, lung, and prostate cancers. Acta Oncol., 1994, vol. 33, no. 3, pp. 293-298.
20. Gordon K., Gulidov I., Fatkhudinov T., Koryakin S., Kaprin A. Fast and furious: fast neutron therapy in cancer treatment. Int. J. Part. Ther., 2022, vol. 9, no. 2, pp. 59-69.
21. Gulidov I., Koryakin S., Fatkhudinov T., Gordon K. External beam fast neutron therapy: Russian clinical experience and prospects for further development. Int. J. Radiat. Oncol. Biol. Phys., 2023, vol. 115, no. 4, pp. 821-827.
22. Gribova O.V., Musabaeva L.I., Choinzonov E.L., Novikov V.A., Lisin V.A. The use of fast neutrons in treatment of malignant tumors of the head and neck. Voprosy Onkologii – Problems in Oncology, 2015, vol. 61, no. 1, pp. 149-153. (In Russian).
23. Munasipov Z.Z., Vazhenin A.V., Lukina E.Yu., Kuznetsova A.I. Ural center for neutron therapy. Results of 10-years labor. Kreativnaya khirurgiya I onkologiya – Creative Surgery and Oncology, 2010, no. 4, pp. 39-41. (In Russian).
24. Kandakova E.Yu., Pryakhin E.A., Vazhenin A.V., Rykovanov G.N., Magda E.P., Mokichev G.V., Mu-nasipov Z.Z., Kuznetsova A.I., Vazhenin I.A. Analysis of the efficiency of a therapeutic program using 10.2-mev fast neutrons. Optimization and prospects of the development of a procedure for combined photon-neu-tron therapy. The experience of the Ural center for neutron therapy. Opukholi golovy i shei – Head and Neck Tumors, 2013, no. 1, pp. 43-48. (In Russian).
25. Ragulin Y., Mardynsky Y., Gulidov I., Aminov G., Medvedev V., Sysoev A., Kotuchov I. 10-year results of complex treatment with reactor neutrons in locally advanced breast cancer (BC). Ann. Oncol., 2015, vol. 26, no. 3 (Suppl.), pp. iii4-iii5. DOI: 10.1093/annonc/mdv114.3.
26. Mardynsky Yu., Gulidov I., Aminov G., Ragulin Yu., Kotuchov I., Gordon K. Reactor neutrons in multimo-dality treatment of locally advanced breast carcinoma. Adv. Mater. Res., 2015, vol. 1084, pp. 464-466.
27. Gulidov I., Sysoev A., Mardynsky Yu., Ulianenko S., Buzaev E., Kononov V., Kononov O., Korobeinikov V., Taskaev S. Fast reactor neutrons in the treatment of malignancies and perspectives of NCT and NCT enhanced fast neutron therapy in Obninsk, Russia. Open Magnetic Systems for Plasma Confinement: Book of Abstracts. Novosibirsk, Siberia: Budker Institute of Nuclear Physics, 2004, pp. 58.
28. Schlea C., Staddard D. Californium isotopes proposed for intracavitary and interstitial radiation therapy with neutrons. Nature, 1965, vol. 206, pp. 1058.
29. Maruyama Y. Neutron brachytherapy for the treatment of malignant neoplasia. Int. J. Radiat. Oncol. Biol. Phys., 1988, vol. 15, no. 6, pp. 1415-1429.
30. Wright C., Boulogne A., Reinig W., Evans A. Implantable californium-252 neutron sources for radiotherapy. Radiology, 1967, vol. 89, no. 2, pp. 337.
31. Galkin V.N., Goverdovsky A.A., Gulidov I.A., Kaprin A.D., Kostin A.A., Krikunova L.I., Konoplyannikov A.G., Mardynsky Yu.S., Medvedev V.S., Chernichenko A.V., Ivanov S.A., Karyakin O.B., Siomin D.Yu., Biryukov V.A., Borysheva N.B., Vlasova O.P., Mkrtchyan L.S., Nerozin N.A., Obukhov A.A., Polkin V.V., Polyakov V.A., Sychenkova N.I., Shapovalova V.V., Burmistrov M.V., Derbugov D.N., Koryakin A.V., Lepilina O.G., Tkachev C.V., Khamjanov S.V. Brachytherapy. Obninsk, NMRRC, 2017. 245 p. (In Russian).
32. Siomin D., Medvedev V., Mardynsky Yu., Gulidov I., Isaev P., Radzhapova M., Derbugov D., Polkin V. Interstitial neutron therapy with 252CF sources for combined therapy of oropharyngeal cancers. Vestnik RONC im. N.N. Blokhina RAMN – Journal of N.N. Blokhin Russian Cancer Research Center RAMS, 2009, vol. 20, no. 2, pp. 50-51. (In Russian).
33. Maruyama Y., van Nagell J.R., Yoneda J., Donaldson E.S., Gallion H.H., Higgins R., Kryscio R.J. Cure of cervical cancer using 252Cf neutron brachytherapy. Strahlenther Onkol., 1990, vol. 166, no. 5, pp. 317-321.
34. Tacev T., Ptácková B., Strnad V. Californium-252 (252Cf) versus conventional gamma radiation in the brachy-therapy of advanced cervical carcinoma long-term treatment results of a randomized study. Strahlenther Onkol. 2003, vol. 179, no. 6, pp. 377-384.
35. Xiong Y., Shan J., Liu J., Zhao K., Chen S., Xu W., Zhou Q., Yang M., Lei X. Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserv-ing radiotherapy. Sci. Rep., 2017, vol. 7, pp. 40619. DOI: 10.1038/srep40619.
36. Jin W.H., Seldon C., Butkus M., Sauerwein W., Giap H.B. A review of boron neutron capture therapy: its history and current challenges. Int. J. Part. Ther., 2022, vol. 9, no. 1, pp. 71-82.
37. Locher G.L. Biological effects and therapeutic possibilities of neutrons Am. J. Roentgenol., 1926, vol. 36, pp. 1-13.
38. Farr L., Sweet W., Locksley H., Robertson J. Neutron capture therapy of gliomas using boron. Trans. Am. Neurol. Assoc., 1954, vol. 13, pp. 110-113.
39. Hatanaka H. Clinical results of boron neutron capture therapy. Basic Life Sci., 1990, vol. 54, pp. 15-21.
40. Nakagawa Y., Pooh K., Kobayashi T., Uyama, S., Matsumura A., Kumada H. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J. Neurooncol., 2003, vol. 62, no. 1-2, pp. 87-99.
41. Hirose K., Konno A., Hiratsuka J., Yoshimoto S., Kato T., Ono K., Otsuki N., Hatazawa J., Tanaka H., Takayama K., Wada H., Suzuki M., Sato M., Yamaguchi H., Seto I., Ueki Y., Iketani S., Imai S., Nakamura T., Ono T., Endo H., Azami Y., Kikuchi Y., Murakami M., Takai Y. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial. Radiother. Oncol., 2021, vol. 155, pp. 182-187.
42. Miyatake S., Kawabata S., Hiramatsu R., Kuroiwa T., Suzuki M., Kondo N., Ono K. Boron neutron capture therapy for malignant brain tumors. Neurol. Med. Chir. (Tokyo), 2016, vol. 56, no. 7, pp. 361-371.
43. Malouff T.D., Seneviratne D.S., Ebner D.K., Stross W.C., Waddle M.R., Trifiletti D.M., Krishnan S. Boron neutron capture therapy: a review of clinical applications. Front. Oncol., 2021, vol. 11, pp. 601820. DOI: 10.3389/fonc.2021.601820.
44. Boron neutron capture therapy using CICS-1 and SPM-011 for malignant melanoma and angiosarcoma. Clin-icalTrials.gov.identifier: NCT04293289. Available at: https://clinicaltrials.gov/ct2/show/NCT04293289 (Ac-cessed 03.04.2023).
Full-text article (in Russian)